Dermal Matrix Research

GLOW Peptide Stack — BPC-157 + TB-500 + GHK-Cu

A Wolverine stack with GHK-Cu added, researched in skin-matrix and collagen models. Laid out here as three individual vials so each peptide's amount can be adjusted independently, rather than as a fixed-ratio premade GLOW blend.

Total program: 12 weeks · 3 individual vials

Why these peptides are researched together

GLOW keeps the Wolverine pair and adds a third pathway. GHK-Cu is a copper-binding peptide studied for fibroblast activity and for collagen and elastin gene expression — the structural proteins of skin and connective tissue. BPC-157 and TB-500 cover local signaling and cell migration; GHK-Cu covers matrix building, which is why the three appear together in dermal and collagen research.

Each peptide at a glance

How the schedules fit together

Three different rhythms: BPC-157 once daily, GHK-Cu once daily 5 days per week, and TB-500 2 days per week in Weeks 1–4, then 1 day per week in Weeks 5–12. All three charts run about 12 weeks, so they start and finish together. GHK-Cu increases in steps at Weeks 5 and 9 on its own chart.

What the research shows

GHK-Cu has the deepest dermal research of the three, including gene-expression and wound-model studies.

Still unproven

The three-peptide combination has not been studied as a unit in published human trials.

FAQs

What is the GLOW Peptide Stack?

A Wolverine stack with GHK-Cu added, researched in skin-matrix and collagen models. Laid out here as three individual vials so each peptide's amount can be adjusted independently, rather than as a fixed-ratio premade GLOW blend.

What's in the GLOW peptide stack?

The GLOW Peptide Stack combines GHK-Cu, BPC-157 and TB-500, each in its own vial. GHK-Cu: Copper-binding tripeptide studied for fibroblast activity, collagen and elastin expression. BPC-157: Studied in local tissue signaling models. TB-500: Studied in cell migration and remodeling models.

What does the GLOW Peptide Stack do?

GLOW keeps the Wolverine pair and adds a third pathway. GHK-Cu is a copper-binding peptide studied for fibroblast activity and for collagen and elastin gene expression — the structural proteins of skin and connective tissue. BPC-157 and TB-500 cover local signaling and cell migration; GHK-Cu covers matrix building, which is why the three appear together in dermal and collagen research.

What is the GLOW Peptide Stack dosage?

The amounts for each peptide are listed week by week in the dosing table on this page, taken from each peptide's full dosing chart, with units on a 100-unit syringe and exact vial counts for the full 12-week program.

How long is the GLOW Peptide Stack?

The GLOW Peptide Stack is laid out as a 12-week research program. Three different rhythms: BPC-157 once daily, GHK-Cu once daily 5 days per week, and TB-500 2 days per week in Weeks 1–4, then 1 day per week in Weeks 5–12. All three charts run about 12 weeks, so they start and finish together. GHK-Cu increases in steps at Weeks 5 and 9 on its own chart.

What does research show about the GLOW Peptide Stack?

GHK-Cu has the deepest dermal research of the three, including gene-expression and wound-model studies. Still unproven: The three-peptide combination has not been studied as a unit in published human trials.

Sources

Other peptide stacks

Educational research reference only. Not medical advice or individualized guidance.